United States
Print page content Print
Increase text size Decrease text size
Text Size

Find and download the latest information about EXCEDE®:

BRD Solutions

EXCEDE is part of the BRD Solutions portfolio. Visit BRD-Solutions.com to learn more about the full portfolio of solutions and find expert advice and tools to help customize a BRD program to your needs.

Technical studies

Tissue distribution of ceftiofur and related metabolites after administration of EXCEDE

Feed intake response following a single dose of EXCEDE or Nuflor®

EXCEDE vs. Micotil® for control of bovine respiratory disease using a post-metaphylaxis interval

Duration of therapy with EXCEDE or Micotil in a bovine respiratory disease challenge model

Outcomes of 3-, 5- or 7-day post-treatment intervals after a single administration of EXCEDE

Efficacy of EXCEDE followed by 3- or 7-day post-treatment intervals vs. Baytril® followed by a 3-day post-treatment interval in treatment of bovine respiratory disease

Administration

Subcutaneous ear route of administration — a new and patented method for delivering liquid anti-infectivesOpens in a new window

Ventral base of ear training video — English

Ventral base of ear training video — Spanish

Rostral base of ear training video — English

Rostral base of ear training video — Spanish

Opposite eye base of ear training video — English

Opposite eye base of ear training video — Spanish

Base of ear material safety data sheetOpens in a new window

Antimicrobial comparison chart

Bovine respiratory disease antimicrobial comparison chartOpens in a new window

  

IMPORTANT SAFETY INFORMATION FOR CATTLE: People with known hypersensitivity to penicillin or cephalosporins should avoid exposure to EXCEDE. EXCEDE is contraindicated in animals with known allergy to ceftiofur or to the ß-lactam group (penicillins and cephalosporins) of antimicrobials. Inadvertent intra-arterial injection is possible and fatal. Do not use in calves to be processed for veal. Pre-slaughter withdrawal time is 13 days following the last dose. See full Prescribing InformationOpens in a new window.